Closed

Targeted Prostate Cancer Screening Programme - MRI Reporting Service

NHS England

Value
£143,654.56
Published
13 Oct 2026
Deadline
10 Nov 2026
Procedure
Open procedure
Location
UK
Notice reference
096478-2026

Requirements summary

NHS England is procuring a national centralised Prostate MRI Reporting Service for the Targeted Prostate Cancer Screening Programme in England, focused on men at increased risk due to an inherited BRCA2 variant. The provider will perform specialist human double reporting, arbitration, structured reporting and secure report return for MRI examinations triggered by above-threshold PSA results. The contract is valued at GBP 143,654.56 over 780 days and is run under the Health Care Services (Provider Selection Regime) Regulations 2023.

Key requirements

  • National centralised prostate MRI reporting service for the Targeted Prostate Cancer Screening Programme in England
  • Specialist human double reporting of prostate MRI, with expert arbitration and lesion delineation where required
  • Image receipt or access, case acceptance, structured report production and authorisation, and secure report return with acknowledgement and Failsafe arrangements
  • Quality assurance, escalation, Programme data reporting, audit and governance participation
  • Contract value GBP 143,654.56 over 780 days; tender submissions via Atamis e-tendering, closing 10 November 2026
  • Excludes diagnostic MRI scanning, PSA testing, biopsy delivery, urology treatment, BRCA genetic testing, BRCA decision-resource development and the national Programme IT system
  • Stage 2 weighting: reader workforce 16%, reporting protocol 16%, Commercial Envelope 20%, Social Value 10%

Similar open notices

Targeted Prostate Cancer Screening Programme - MRI Repo… | ProposAI